1. Turley, S.D., and Dietschy, J.M. (1982) inThe Liver: Biology and Pathobiology (Arias, I., Popper, H., Schachter, D., and Shafritz, D.A., eds.) pp. 467–492, Raven Press, New York.
2. Goldstein, J.L., and Brown, M.S. (1990) Regulation of the Mevalonate Pathway,Nature 343, 425–430.
3. Davignon, J., Montigny, M., and Dufour, R. (1992) HMG-CoA Reductase Inhibitors: A Look Back and a Look Forward,Can. J. Cardiol. 8, 843–864.
4. Feussner, G. (1994) HMG CoA Reductase Inhibitors,Curr. Opin. Lipidol., 5, 59–68.
5. Blum, C.B. (1994) Comparison of Properties of Four Inhibitors of 3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase,Am. J. Cardiol. 73, 3D-11D.